Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Gut microbiota modulation to boost antitumor immune responses is under investigation (1).
XXX - ROMA-2 - Chemoradiotherapy (CRT) + Microbial ecosystem therapeutic 4 (MET4) & Oropharyngeal cancer (HPV +) is a small clinical trial studying Chemoradiotherapy (CRT) + Microbial Ecosystem Therapeutics 4 (MET-4) in 29 patients with Oropharyngeal cancer (HPV +) (1).
Safety, ecological endpoints (1).
A total of 29 patients received at least one dose of MET-4 and were assessed for safety. Drug-related adverse events (AEs) were observed in 13 out of 29 patients. Most of these AEs were mild to moderate (gra…